Diligence memo · auto-generated · as of July 2, 2026
Spearhead Bio, Inc.
Spearhead Bio, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Spearhead Bio, Inc. operates in Biotech / Pharma, based in SAINT LOUIS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Spearhead Bio, Inc. has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.0M on 2025-02-06.
Most recent recorded round closed around 2025-02-06.
Valuation (modeled)modeled
Provath models Spearhead Bio, Inc. at approximately $3.6M (range $756K–$8.1M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.00× the median modeled value of Seed Biotech / Pharma companies in 2025–2027 (5 peers) — value vs value, same stage and era. Within the normal band (100% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 17 mo ago; this sector typically re-raises about every 15 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 31% of Biotech / Pharma peers (227 compared).
Modeled value ranks above 21% of those peers.
Closest niche peers: Pluto Biosciences, Inc., Chirality Biosciences, Inc., PharmaWaste Ventures, LLC, Catch Bio, Inc..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.